ArticleActa pharmaceutica Sinica. B2026

Hypoxia-selective targeting of eEF1A1: A promising therapeutic strategy for triple-negative breast cancer.

Steven H LiangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.